{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T01:54:58Z","timestamp":1782266098455,"version":"3.54.5"},"reference-count":25,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.3892\/etm.2012.847","type":"journal-article","created":{"date-parts":[[2012,11,30]],"date-time":"2012-11-30T13:43:23Z","timestamp":1354283003000},"page":"626-630","source":"Crossref","is-referenced-by-count":14,"title":["Determination of thalidomide concentration in human plasma by liquid chromatography-tandem mass spectrometry"],"prefix":"10.3892","volume":"5","author":[{"given":"NAN","family":"BAI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XIANG-YONG","family":"CUI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JIN","family":"WANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CHUN-GUANG","family":"SUN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HE-KUN","family":"MEI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BEI-BEI","family":"LIANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YUN","family":"CAI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XIU-JIE","family":"SONG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JING-KAI","family":"GU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RUI","family":"WANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2012,11,30]]},"reference":[{"key":"key20180108122102_b1-etm-05-02-0626","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1517\/13543784.7.12.2043","article-title":"Thalidomide revisited: pharmacology and clinical applications","volume":"7","author":"Calabrese","year":"1998","journal-title":"Expert Opin Investig Drugs"},{"key":"key20180108122102_b2-etm-05-02-0626","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1517\/14740338.3.1.47","article-title":"Thalidomide: an old drug with new clinical applications","volume":"3","author":"Laffitte","year":"2004","journal-title":"Expert Opin Drug Saf"},{"key":"key20180108122102_b3-etm-05-02-0626","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1248\/bpb.29.2331","article-title":"The pharmacokinetics of low-dose thalidomide in Japanese patients with refractory multiple myeloma","volume":"29","author":"Kamikawa","year":"2006","journal-title":"Biol Pharm Bull"},{"key":"key20180108122102_b4-etm-05-02-0626","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/sj.thj.6200175","article-title":"Thalidomide in patients with advanced multiple myeloma: a study of 83 patients - report of the Intergroupe Francophone du My\u00e9lome (IFM)","volume":"3","author":"Yakoub-Agha","year":"2002","journal-title":"Hematol J"},{"key":"key20180108122102_b5-etm-05-02-0626","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1182\/asheducation-2003.1.248","article-title":"Advances in biology and therapy of multiple myeloma. Hematology","author":"Barill\u00e9-Nion","year":"2003","journal-title":"Am Soc Hematol Educ Program"},{"key":"key20180108122102_b6-etm-05-02-0626","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.jpeds.2004.08.020","article-title":"Thalidomide for severe systemic onset juvenile rheumatoid arthritis: A multicenter study","volume":"145","author":"Lehman","year":"2004","journal-title":"J Pediatr"},{"key":"key20180108122102_b7-etm-05-02-0626","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1067\/mpd.2002.120695","article-title":"Esophagitis in distressed infants: poor diagnostic agreement between esophageal pH monitoring and histopathologic findings","volume":"140","author":"Heine","year":"2002","journal-title":"J Pediatr"},{"key":"key20180108122102_b8-etm-05-02-0626","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.berh.2006.03.003","article-title":"Ankylosing spondylitis and symptom-modifying vs disease-modifying therapy","volume":"20","author":"Akkoc","year":"2006","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"6 Suppl 28","key":"key20180108122102_b9-etm-05-02-0626","first-page":"S67","article-title":"Treatment of ankylosing spondylitis with disease modifying antirheumatic drugs","volume":"20","author":"van der Horst-Bruinsma","year":"2002","journal-title":"Clin Exp Rheumatol"},{"key":"key20180108122102_b10-etm-05-02-0626","first-page":"730","article-title":"Ankylosing spondylitis - the current situation and new therapeutic options","volume":"52","author":"Zlnay","year":"2006","journal-title":"Vnitr Lek"},{"key":"key20180108122102_b11-etm-05-02-0626","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1365-2036.2007.03385.x","article-title":"A randomized, double-blind, placebo-controlled trial of lenalidomide in the treatment of moderately severe active Crohn\u2019s disease","volume":"26","author":"Mansfield","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"key20180108122102_b12-etm-05-02-0626","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/1097-0029(20000801)50:3<229::AID-JEMT6>3.0.CO;2-H","article-title":"Anti-TNF therapies in rheumatoid arthritis, Crohn\u2019s disease, sepsis, and myelodysplastic syndromes","volume":"50","author":"Raza","year":"2000","journal-title":"Microsc Res Tech"},{"key":"key20180108122102_b13-etm-05-02-0626","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0151-9638(05)79503-X","article-title":"Thalidomide in the treatment of chronic discoid lupus erythematosus","volume":"132","author":"Brocard","year":"2005","journal-title":"Ann Dermatol Venereol"},{"key":"key20180108122102_b14-etm-05-02-0626","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3349\/ymj.1997.38.6.401","article-title":"Treatment of Beh\u00e7et\u2019s disease","volume":"38","author":"Bang","year":"1997","journal-title":"Yonsei Med J"},{"key":"key20180108122102_b15-etm-05-02-0626","doi-asserted-by":"crossref","first-page":"5949","DOI":"10.1158\/1078-0432.CCR-04-0421","article-title":"Thalidomide pharmacokinetics and metabolite formation in mice, rabbits, and multiple myeloma patients","volume":"10","author":"Chung","year":"2004","journal-title":"Clin Cancer Res"},{"key":"key20180108122102_b16-etm-05-02-0626","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0378-4347(92)80321-G","article-title":"Determination of thalidomide in plasma and blood by high-performance liquid chromatography: avoiding hydrolytic degradation","volume":"582","author":"Eriksson","year":"1992","journal-title":"J Chromatogr"},{"key":"key20180108122102_b17-etm-05-02-0626","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/bmc.466","article-title":"Concurrent determination of thalidomide in rat blood, brain and bile using multiple microdialysis coupled to liquid chromatography","volume":"19","author":"Huang","year":"2005","journal-title":"Biomed Chromatogr"},{"key":"key20180108122102_b18-etm-05-02-0626","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1177\/009127009903901108","article-title":"Single-dose oral pharmacokinetics of three formulations of thalidomide in healthy male volunteers","volume":"39","author":"Teo","year":"1999","journal-title":"J Clin Pharmacol"},{"key":"key20180108122102_b19-etm-05-02-0626","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jpba.2008.01.003","article-title":"High performance liquid chromatographic determination of thalidomide in patients affected by hepatocellular carcinoma","volume":"48","author":"Saccomanni","year":"2008","journal-title":"J Pharm Biomed Anal"},{"key":"key20180108122102_b20-etm-05-02-0626","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jpba.2005.02.041","article-title":"Determination of thalidomide by high performance liquid chromatography: plasma pharmacokinetic studies in the rat","volume":"39","author":"Yang","year":"2005","journal-title":"J Pharm Biomed Anal"},{"key":"key20180108122102_b21-etm-05-02-0626","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S0090-9556(25)07646-9","article-title":"Plasma pharmacokinetics and urinary excretion of thalidomide after oral dosing in healthy male volunteers","volume":"17","author":"Chen","year":"1989","journal-title":"Drug Metab Dispos"},{"key":"key20180108122102_b22-etm-05-02-0626","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S1570-0232(02)00911-X","article-title":"Determination of thalidomide in transport buffer for Caco-2 cell monolayers by high-performance liquid chromatography with ultraviolet detection","volume":"785","author":"Zhou","year":"2003","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"key20180108122102_b23-etm-05-02-0626","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0378-4347(99)00345-X","article-title":"Quantitative determination of thalidomide in human serum with high-performance liquid chromatography using protein precipitation with trichloroacetic acid and ultraviolet detection","volume":"734","author":"Tora\u00f1o","year":"1999","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"key20180108122102_b24-etm-05-02-0626","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S1570-0232(01)00563-3","article-title":"Sensitive and rapid method for the determination of thalidomide in human plasma and semen using solid-phase extraction and liquid chromatography-tandem mass spectrometry","volume":"767","author":"Teo","year":"2002","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"key20180108122102_b25-etm-05-02-0626","first-page":"1355","article-title":"Thalidomide is distributed into human semen after oral dosing","volume":"29","author":"Teo","year":"2001","journal-title":"Drug Metab Dispos"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/etm.2012.847\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:36:14Z","timestamp":1745368574000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/etm.2012.847"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,30]]},"references-count":25,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2012,11,30]]},"published-print":{"date-parts":[[2013,2]]}},"alternative-id":["10.3892\/etm.2012.847"],"URL":"https:\/\/doi.org\/10.3892\/etm.2012.847","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,30]]}}}